Community
TrustFinance is trustworthy and accurate information you can rely on. If you are looking for financial business information, this is the place for you. All-in-One source for financial business information. Our priority is our reliability.

TrustFinance Global Insights
5月 05, 2026
2 min read
27

Sweden's stock market concluded Tuesday's trading session on a positive note, with the benchmark OMX Stockholm 30 index rising by 1.22%. The upward momentum was primarily fueled by strong performances in the Basic Materials, Industrials, and Financials sectors, indicating broad-based investor confidence in key areas of the economy.
The overall market sentiment was positive, as rising stocks outnumbered declining ones on the Stockholm Stock Exchange by 378 to 370, with 57 stocks closing unchanged. Among the top performers on the OMX 30, Epiroc AB Class A led the gains with a 3.02% increase. It was followed by ABB Ltd, which added 2.89% to reach a new all-time high, and Boliden AB, which rose by 2.81%.
Despite the overall index gain, several major companies faced downward pressure. AstraZeneca PLC was among the worst performers, declining by 1.75%. Similarly, Evolution AB fell by 1.35%, and NIBE Industrier AB ser. B registered a modest loss of 0.65%. These movements highlight a mixed performance among individual large-cap stocks within the index.
The Swedish market demonstrated resilience, closing higher despite some notable individual stock declines. The strength in industrial and materials sectors suggests a positive outlook, though investors will continue to monitor the performance of major international companies like AstraZeneca for future market direction.
Q: What was the main driver for the Swedish stock market's rise?
A: The primary drivers were significant gains in the Basic Materials, Industrials, and Financials sectors.
Q: Which company was the top performer in the OMX Stockholm 30?
A: Epiroc AB Class A was the session's best performer, with its shares rising by 3.02%.
Q: Did all major stocks perform well?
A: No, some prominent stocks like AstraZeneca PLC and Evolution AB experienced declines of 1.75% and 1.35%, respectively.
Source: Investing.com

TrustFinance Global Insights
AI-assisted editorial team by TrustFinance curating reliable financial and economic news from verified global sources.
Related Articles